Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
5(35.7%)
Phase 4
4(28.6%)
N/A
3(21.4%)
Phase 3
1(7.1%)
Phase 1
1(7.1%)
14Total
Phase 2(5)
Phase 4(4)
N/A(3)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT02444286Withdrawn

The RESHAPE-HF1-FU Study

Role: lead

NCT01485978Phase 3Completed

Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome

Role: lead

NCT01855035Not ApplicableCompleted

Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring

Role: lead

NCT01355913Completed

Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

Role: lead

NCT00785330Phase 2Completed

Allo-hNHL (FluBuCy)

Role: lead

NCT01474265Phase 4Completed

Sympathovagal Balance in Smoking Cessation

Role: lead

NCT01488955Phase 4Completed

Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI

Role: lead

NCT01845194Phase 1Completed

Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

Role: lead

NCT00783120Not ApplicableCompleted

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia

Role: lead

NCT01831947Phase 4Completed

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

Role: lead

NCT00521560Phase 2Completed

A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas

Role: lead

NCT01415622Not ApplicableCompleted

Feasibility, Efficacy, and Safety of Venous Ulcer Treatment Using a Hand Plasma Generator (PlasmaDerm) Chronisch venöser Ulzerationen (PlasmaDerm)

Role: collaborator

NCT00355095Phase 2Completed

Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis

Role: lead

NCT01176721Phase 2Completed

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Role: collaborator

NCT00511277Phase 4Completed

Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study

Role: lead

NCT00561587Phase 2Completed

Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

Role: lead

All 16 trials loaded